About
Small Molecule
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
2,192
By Phase
PHASE3: 1PHASE2: 1
By Status
UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT03970031Lead Sponsor
A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH
PHASE3Unknown
1,800 participants
Started: Jun 30, 2022 · Completed: Sep 30, 2024
NCT02784444Lead Sponsor
A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH
PHASE2Completed
392 participants
Started: Sep 14, 2016 · Completed: Jun 30, 2019
Locations (1)
Headquarters
Kalamazoo, MI, United States
Map
Loading map...